Personally, I think if a phase 3 or phase 4 trial came up with GS7977 for G1a's with Cirrhosis, my husband would probably try to enroll if his hepatologist thought it would be a good idea, primarily because at his stage of liver damage and his age there is a risk to waiting for new treatments to be approved.